Company Profiles

driven by the PitchBook Platform

Abgentis

Description

Provider of antibacterials treatments. The company provides treatment for life-threatening and drug-resistant bacterial infections by increasing the immune system of body through using microbiology, pharmacology and efficacy of antibacterial DNA super coiling inhibitors.

2012

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$333k

Latest Deal Amount

$333k

Total Amount Raised

2

Investors

Description

Provider of antibacterials treatments. The company provides treatment for life-threatening and drug-resistant bacterial infections by increasing the immune system of body through using microbiology, pharmacology and efficacy of antibacterial DNA super coiling inhibitors.

Website:

www.abgentis.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Healthcare

Primary Office

Birmingham Research Park Vincent Drive Edgbaston B15 2SQEngland +44 (0)12 3553 2481
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Abgentis's full profile, request a free trial.

Abgentis Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Abgentis Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
MidvenVenture CapitalMinority000 0000000 0000
Oxford TechnologyVenture CapitalMinority000 0000000 0000
Midven Venture Capital
Oxford Technology Venture Capital

Abgentis Board Members (2)

NameRepresentingRoleSinceContact
Info
Andy MuirSelfBoard Member000 0000
Lloyd CzaplewskiAbgentisBoard Member & Founder000 0000
Andy Muir Board Member Self
Lloyd Czaplewski Board Member & Founder Abgentis
Request full access to PitchBook